Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12648094 | 1.00 | KDM4E (0.45) | KDM4ELMNACYP2C19TSHRNPSR1 | |
| SCHEMBL16179651 | 1.00 | KDM4E (0.45) | KDM4ELMNACYP2C19TSHRNPSR1 | |
| SCHEMBL8605321 | 0.94 | KDM4E (0.43) | KDM4ELMNACYP2C19TSHRNPSR1 | |
| SCHEMBL7752623 | 0.86 | — | — | |
| SCHEMBL28747920 | 0.86 | KDM4E (0.43) | KDM4ELMNACYP2C19TSHRNPSR1 | |
| SCHEMBL20204315 | 0.83 | KDM4E (0.33) | KDM4ELMNACYP2C19 | |
| SCHEMBL16391571 | 0.81 | TRIM24 (0.31) | KDM4ELMNACYP2C19TRIM24TRIM33 | |
| SCHEMBL16317445 | 0.80 | SIRT2 (0.36) | KDM4ELMNACYP2C19 | |
| SCHEMBL16193210 | 0.80 | SIRT2 (0.36) | KDM4ELMNACYP2C19 | |
| SCHEMBL17582524 | 0.80 | SIRT2 (0.36) | KDM4ELMNACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9636670-B2 | Catalysts, ligands and use thereof | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2017-05-02 | — | — | US | disclosed |
| US-20160074852-A1 | CATALYSTS, LIGANDS AND USE THEREOF | ISIS INNOVATION LIMITED (GB) | 2016-03-17 | — | — | US | disclosed |
| EP-2986375-A2 | CATALYSTS, LIGANDS AND USE THEREOF | Isis Innovation Limited (GB) | 2016-02-24 | — | — | EP | disclosed |
| WO-2014170642-A2 | CATALYSTS, LIGANDS AND USE THEREOF | ISIS INNOVATION LIMITED (GB) | 2014-10-23 | — | — | WO | disclosed |
| US-7727979-B2 | Guanidine derivatives and their use as neuropeptide FF receptor antagonists | ACTELION PHARMACEUTICALS LTD. (CH) | 2010-06-01 | — | — | US | disclosed |
| US-20060194788-A1 | Guanidine derivatives and their use as neuropeptide ff receptor antagonists | ACTELION PHARMACEUTICALS LTD. (CH) | 2006-08-31 | — | — | US | disclosed |
| EP-1608662-A1 | GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2005-12-28 | — | — | EP | disclosed |
| WO-2004083218-A1 | GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2004-09-30 | — | — | WO | disclosed |
| US-5908945-A | COPPER COMPOUND AND SILYL REAGENT AS CATALYSTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-06-01 | — | — | US | disclosed |
| CN-1039023-C | Film of polycarbonate | BAYER AG (DE) | 1998-07-08 | — | — | CN | disclosed |
| EP-0393454-A2 | Heat-resistant polycarbonate moulding composition | BAYER AG (DE) | 1990-10-24 | — | — | EP | disclosed |
| US-4964890-A | GAS-PERMEABLE FILMS OF A THERMOPLASTIC POLYETHER HAVING DIHYDROXYBENZOPHENONE AND DIHYDROXYDIPHENYLCYCLOALKANE UNITS; DIMENSIONAL STABILITY; HEAT RESISTANCE; MEMBRANES | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-23 | — | — | US | disclosed |
| EP-0365917-A1 | Polymer mixtures | BAYER AG (DE) | 1990-05-02 | — | — | EP | disclosed |
| EP-0365916-A1 | Polymer mixtures | BAYER AG (DE) | 1990-05-02 | — | — | EP | disclosed |
| EP-0364741-A1 | Aromatic polyetherketones | BAYER AG (DE) | 1990-04-25 | — | — | EP | disclosed |
| CN-1041606-A | The mixture of special polycarbonates and other thermoplastics elastomer-formings | BAYER AG (DE) | 1990-04-25 | — | — | CN | disclosed |
| EP-0362603-A1 | Aromatic Polyethersulfones | BAYER AG (DE) | 1990-04-11 | — | — | EP | disclosed |
| EP-0362646-A2 | Mixture of special polycarbonates and other thermoplasts or elastomers | BAYER AG (DE) | 1990-04-11 | — | — | EP | disclosed |
| CN-1041151-A | Dihydroxydiphenylcycloalkanes, process for their preparation and their use for preparing high molecular weight polycarbonates | BAYER AG (DE) | 1990-04-11 | — | — | CN | disclosed |
| EP-0359953-A1 | Dihydroxydiphenylcycloalkanes, their preparation and their use for the preparation of high molecular polycarbonates | BAYER AG (DE) | 1990-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060194788-A1 | Guanidine derivatives and their use as neuropeptide ff receptor antagonists | NPFFR1, OGFR, NPFFR2 | KDM4E 3147/4885LMNA 2988/4885CYP2C19 3689/4885 |
| US-20160074852-A1 | CATALYSTS, LIGANDS AND USE THEREOF | SPR, SQOR, COASY | KDM4E 2877/4885LMNA 3379/4885CYP2C19 438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.